Marga Lang-Welzenbach

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

Claus Rödel, Ullrich Graeven, Rainer Fietkau et al. · The Lancet Oncology · 2015 · 724 citations

Medicine, Oncology, Surgery +16

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

Claus Rödel, Torsten Liersch, Heinz Becker et al. · The Lancet Oncology · 2012 · 700 citations

Medicine, Oncology, Surgery +17

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat et al. · JAMA Oncology · 2021 · 354 citations · Full text

Medicine, Surgery, Gastrointestinal Oncology +13

Phase I Trial of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer

Thomas Brunner, Matthias Geiger, Gerhard G. Grabenbauer et al. · Journal of Clinical Oncology · 2008 · 156 citations · Full text

Medicine, Oncology, Pharmacology +16

Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial.

Claus Röedel, Heinz Becker, Rainer Fietkau et al. · Journal of Clinical Oncology · 2011 · 80 citations

Medicine, Oncology, Surgery +16